Author
Listed:
- Uschi Lindert
(Connective Tissue Unit and Children’s Research Center, University Children’s Hospital Zurich)
- Wayne A. Cabral
(Section on Heritable Disorders of Bone and Extracellular Matrix, National Institute of Child Health and Human Development, National Institutes of Health)
- Surasawadee Ausavarat
(Center of Excellence for Medical Genetics, Faculty of Medicine, Chulalongkorn University
Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society
Present address: Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand)
- Siraprapa Tongkobpetch
(Center of Excellence for Medical Genetics, Faculty of Medicine, Chulalongkorn University
Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society)
- Katja Ludin
(Center for Laboratory Medicine)
- Aileen M. Barnes
(Section on Heritable Disorders of Bone and Extracellular Matrix, National Institute of Child Health and Human Development, National Institutes of Health)
- Patra Yeetong
(Center of Excellence for Medical Genetics, Faculty of Medicine, Chulalongkorn University
Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society
Present address: Division of Human Genetics, Department of Botany, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand)
- Maryann Weis
(University of Washington)
- Birgit Krabichler
(Medical University of Innsbruck)
- Chalurmpon Srichomthong
(Center of Excellence for Medical Genetics, Faculty of Medicine, Chulalongkorn University
Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society)
- Elena N. Makareeva
(Section on Physical Biochemistry, National Institute of Child Health and Human Development, National Institutes of Health)
- Andreas R. Janecke
(Medical University of Innsbruck
Medical University of Innsbruck)
- Sergey Leikin
(Section on Physical Biochemistry, National Institute of Child Health and Human Development, National Institutes of Health)
- Benno Röthlisberger
(Center for Laboratory Medicine)
- Marianne Rohrbach
(Connective Tissue Unit and Children’s Research Center, University Children’s Hospital Zurich)
- Ingo Kennerknecht
(Institute of Human Genetics, Westfälische Wilhelms University)
- David R. Eyre
(University of Washington)
- Kanya Suphapeetiporn
(Center of Excellence for Medical Genetics, Faculty of Medicine, Chulalongkorn University
Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society)
- Cecilia Giunta
(Connective Tissue Unit and Children’s Research Center, University Children’s Hospital Zurich)
- Joan C. Marini
(Section on Heritable Disorders of Bone and Extracellular Matrix, National Institute of Child Health and Human Development, National Institutes of Health)
- Vorasuk Shotelersuk
(Center of Excellence for Medical Genetics, Faculty of Medicine, Chulalongkorn University
Excellence Center for Medical Genetics, King Chulalongkorn Memorial Hospital, The Thai Red Cross Society)
Abstract
Osteogenesis imperfecta (OI) is a collagen-related bone dysplasia. We identified an X-linked recessive form of OI caused by defects in MBTPS2, which encodes site-2 metalloprotease (S2P). MBTPS2 missense mutations in two independent kindreds with moderate/severe OI cause substitutions at highly conserved S2P residues. Mutant S2P has normal stability, but impaired functioning in regulated intramembrane proteolysis (RIP) of OASIS, ATF6 and SREBP transcription factors, consistent with decreased proband secretion of type I collagen. Further, hydroxylation of the collagen lysine residue (K87) critical for crosslinking is reduced in proband bone tissue, consistent with decreased lysyl hydroxylase 1 in proband osteoblasts. Reduced collagen crosslinks presumptively undermine bone strength. Also, proband osteoblasts have broadly defective differentiation. These mutations provide evidence that RIP plays a fundamental role in normal bone development.
Suggested Citation
Uschi Lindert & Wayne A. Cabral & Surasawadee Ausavarat & Siraprapa Tongkobpetch & Katja Ludin & Aileen M. Barnes & Patra Yeetong & Maryann Weis & Birgit Krabichler & Chalurmpon Srichomthong & Elena N, 2016.
"MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta,"
Nature Communications, Nature, vol. 7(1), pages 1-12, September.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11920
DOI: 10.1038/ncomms11920
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11920. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.